Peter Kellman, PhD

Senior Scientist
National Institutes of Health, Maryland, United States

Disclosure information not submitted.

Presentation(s):

• 1338633 - Dark blood PSIR LGE with AI denoising speeds acquisition by 50%

  Wednesday, January 25, 2023

• 1342938 - Real-time Cine imaging with Convolutional Neural Network Transformer (CNNT) for Denoising

  Wednesday, January 25, 2023

• 1346611 - Optimal method of measuring LV mass: an AI test-retest study

  Wednesday, January 25, 2023

• 1351683 - Smooth and trabeculated left ventricular reference ranges on 4405 healthy subjects; integrating AI analysis with in-line deployment

  Wednesday, January 25, 2023

• 1351740 - Stress Myocardial Blood Flow is Abnormal During Acute Takotsubo Syndrome

  Wednesday, January 25, 2023

• 1355885 - Inclusion of papillary muscle mass and trabeculations in left ventricular assessment correlates more closely to total LVM in diseases of left ventricular hypertrophy.

  Wednesday, January 25, 2023

• 1356599 - Free-breathing mSASHA extracellular volume in patients is significantly lower than MOLLI in accordance with previous experimental data

  Wednesday, January 25, 2023

• 1357002 - Multiparametric SASHA combined T1 and T2 mapping: sex related differences and reference ranges at 1.5T

  Wednesday, January 25, 2023

• 1357617 - Sex-specific Predictors of Coronary Microvascular Function in a Cohort of Asymptomatic People With Type 2 Diabetes

  Wednesday, January 25, 2023

• Talk 2 - Late Gadolinium Enhancement Imaging: Psir, Wideband, Dark Blood And Artifacts

  Wednesday, January 25, 2023
  2:15 PM – 2:30 PM

• 1350544 - Cardiovascular adaptations to acute hemodynamic stress in type 2 diabetes coexistent with overweight/obesity

  Thursday, January 26, 2023
  8:20 AM – 8:30 AM

• 1351339 - Persistent maternal cardiac changes twelve-month post-partum in women with gestational diabetes mellitus

  Thursday, January 26, 2023
  8:30 AM – 8:40 AM

• 1350520 - CNNT denoising for cine imaging at 0.55T with higher acceleration rates

  Thursday, January 26, 2023
  10:40 AM – 10:50 AM

• 1339184 - Myocardial perfusion reserve assessed by quantitative CMR is lower in heart transplant patients than in healthy controls and is related to exercise capacity

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1341596 - The force-frequency relationship and its effects on myocardial blood flow in chronic heart failure patients with cardiac implantable electronic devices assessed by cardiac magnetic resonance imaging

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1344149 - Global Myocardial Ischemia in Severe Aortic Stenosis Reverses Early after Aortic Valve Replacement

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1345099 - Coexistent diabetes is associated with residual myocardial abnormalities after aortic valve replacement in patients with severe aortic stenosis

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1345885 - Myocardial perfusion reserve by quantitative perfusion CMR in dilated cardiomyopathy: association with major adverse cardiovascular events

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1347557 - Does Diabetes Lead to Distinct Alterations in Aortic Stenosis? Insights from Multiparametric CMR and Circulating Biomarkers

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1349779 - Artificial Intelligence-measured MAPSE by CMR Unveils Early Left Ventricular Dysfunction in Aortic Stenosis and Predicts Worse Outcome

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1354976 - Prevalence of asymmetric septal hypertrophy (ASH) in hypertrophic cardiomyopathy (HCM) and mimics

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1351229 - Liraglutide treatment improves myocardial energetics and stress perfusion in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial

  Thursday, January 26, 2023
  2:50 PM – 3:00 PM

• 1356800 - RAPID-Cardiotoxicity screening: image to report in 13 minutes

  Thursday, January 26, 2023
  3:00 PM – 3:10 PM

• 1344422 - Reduced stress perfusion and coronary microvascular dysfunction in follow-up after hospitalization due to severe Covid-19

  Thursday, January 26, 2023
  2:10 PM – 2:20 PM

• 1349845 - Adverse cardiovascular outcomes in diabetic patients with heart failure are mediated by silent ischaemic heart disease

  Thursday, January 26, 2023
  4:30 PM – 5:10 PM

• 1350622 - Reliability of fully automated, inline quantitative assessment of myocardial perfusion in patients with suspected coronary artery disease

  Thursday, January 26, 2023
  4:30 PM – 5:10 PM

• 1354849 - Diagnostic confidence with quantitative CMR perfusion mapping increases with increased coverage of the left ventricle

  Thursday, January 26, 2023
  4:30 PM – 5:10 PM

• 1356594 - A Radiographer’s Evaluation of a Rapid Stress Perfusion CMR Protocol.

  Friday, January 27, 2023
  8:35 AM – 8:42 AM

• 1356971 - Waiting list backlog reduction with rapid scanning and AI-enabled reporting

  Friday, January 27, 2023
  9:50 AM – 10:00 AM

• 1342258 - Myocardial edema in aortic stenosis: insights from multiparametric SASHA

  Friday, January 27, 2023
  10:20 AM – 11:00 AM

• 1344061 - Rapid Myocyte Regression After Aortic Valve Replacement in Severe Aortic Stenosis

  Friday, January 27, 2023
  10:20 AM – 11:00 AM

• 1356119 - Advanced structural phenotype changes in hypertrophic cardiomyopathy from subclinical to overt disease: a 200-subject multicenter study

  Friday, January 27, 2023
  10:20 AM – 11:00 AM

• 1347558 - Association of myocardial tissue characteristics on CMR with recovery of cardiac function in patients with HFrEF

  Friday, January 27, 2023
  12:20 PM – 1:20 PM

• 1349688 - The impact of water exchange on estimates of extracellular volume calculated using contrast enhanced T1 measurements in patients with severe aortic stenosis

  Friday, January 27, 2023
  12:20 PM – 1:20 PM

• 1355246 - Discriminating hypertrophic cardiomyopathy (HCM) patients from healthy, athletic, and hypertensive patients using pure shape analysis

  Friday, January 27, 2023
  2:18 PM – 2:30 PM

• Talk 2: Quantification in MR-perfusion

  Saturday, January 28, 2023
  10:40 AM – 11:00 AM

• Panel Discussion

  Saturday, January 28, 2023
  11:00 AM – 11:20 AM